Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[cited 2024 Jul 24]
Obesity medication coverage has historically faced barriers, though recent precedents with Wegovy and Zepbound approvals suggest improving coverage landscape
Arrigo, A., Casale, R., Buonocore, M., and Ciano, C
CONCLUDING REMARKS AND FUTURE DIRECTIONS None Acknowledgements ACKNOWLEDGMENTS CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported
Lancet 402 , 429431 (2023)
{Jrgensen, S.W., Hjort, L., Gillberg, L., Justesen, L., Madsbad, S., Brns, C., Vaag, A.A
US$ 24.22
US$ 21.45
US$ 26.47
US$ 27.90
US$ 20.51
US$ 25.96
